(Total Views: 504)
Posted On: 03/29/2019 1:05:40 PM
Post# of 74

$SGEN News Article - Seattle Genetics Completes Enrollment in Phase 2 Clinical Trial of Tisotumab Vedotin in Recurrent or Metastatic Cervical Cancer https://marketwirenews.com/news-releases/seat...12416.html


My Twitter: WhyteStocks